B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,181 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 905
Ph III recruiting: 103
Growth YoY: +3.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 1,351–1,400 of 2,052 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05366881	cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease(CAMPERR)	recruiting	—	7,000	Adela, IncINDUSTRY	1	Jan 20, 2026	clinicaltrials
NCT07185490	IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma(IASO104)	not yet recruiting	Early Phase 1	40	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER